Global DNA Sequencing: Research, Applied and Clinical Markets

Publish Date: May 2019 | Category: Biotechnology | Publisher: BCC Research | Status: Publish

The global sequencing market should grow from $10.7 billion in 2018 to $24.4 billion by 2023, with a compound annual growth rate (CAGR) of 18.0% for the period of 2018-2023.

Report Scope:

The scope of the report includes sequencing technologies, applications, industries, initiatives, patents and companies. The markets for sequencing products and services are given for the years 2017, 2018, and 2023.

This report reviews the main sequencing technologies and explains why genetic variation is important in clinical testing. It then discusses some of the significant research initiatives that impact sequencing applications. Of particular interest is a discussion of population-scale sequencing projects throughout the world, and their likely impact on the sequencing industry. The main market driving forces for sequencing products and services are listed and discussed.

The report quantifies the sequencing markets by delivered format, including sequencing workflow products (sample preparation kits and reagents, sequencing instruments and consumables, and informatics) and sequencing services (clinical diagnostics and sequencing services to applied market customers).
The sample preparation kits and reagents market is quantified by type, that is, DNA isolation and extraction; target enrichment; and library preparation. The sequencing instruments and consumables market given by platform (Sanger, NGS and 3GS) and by product type (instruments, consumables).

The sequencing services market is analyzed by end user application (applied, clinical, research and development) and by genome type (human, non-human). Within sequencing services, the applied market is analyzed by end user application (agriculture, biopharma, consumer, microbiology, population-scale genomics, synthetic biology, and other).

Also within sequencing services, the clinical market is analyzed and quantified on a number of levels, including by disease category (cardiovascular, clinical microbiology and infectious diseases, Mendelian disorders, metabolic/immune disorders, neurology, oncology, reproductive health, and transplant medicine); by sequenced region (single gene, targeted region/multi-gene, exome, whole genome, and metagenome); by assay type (screening/early detection, diagnosis, therapy guidance, monitoring).

Within the diagnostics market, the oncology, reproductive health and transplant medicine market segments are analyzed as follows. The oncology market segment is analyzed by assay type; by sequenced region; and by indication (bladder, brain, breast, colorectal, cancer unknown primary, gastrointestinal stromal tumor, kidney, leukemia/lymphoma, lung, melanoma, pan-cancer, prostate, thyroid, and other cancer). The reproductive health market segment is analyzed by assay type; sequenced region; and application (carrier screening, in-vitro fertilization, newborn screening and non-invasive prenatal screening). The transplant market segment is analyzed by assay type; sequenced region; and organ type (lung, heart, liver, and kidney).

Specific geographic markets are discussed, including North America, Europe, Asia-Pacific, and the rest of the world.

Industry sectors analyzed include Sequencing instruments; long-read sequencing; target enrichment; gene editing; informatics; blockchain; liquid biopsy; reproductive health diagnostics; consumer genomics; agriculture; and DNA data storage.

More than 200 companies in the sequencing industry are profiled in this report.

BCC Research provides a summary of the more than 200 of the main industry acquisitions and strategic alliances from January 2017 through March 2019, including key alliance trends.

Report Includes:

- 27 data tables and 79 additional tables
- An overview of global market for DNA sequencing and discussion of applications in research, applied and clinical markets
- Analyses of global market trends, with data from 2017, 2018, and projections of compound annual growth rates (CAGRs) through 2023
- Description of sequencing markets by workflow, including sample preparation products; sequencing instruments and consumables; informatics; and sequencing services
- Coverage of Sanger and next-generation technologies in detail
- Detailed description of key sequencing research & development programs such as American Gut Consortium, BabySeq and Blood Profiling Atlas
- A look at the current trends and recent developments in the market
- Company profiles of the major players of the market, including 23Andme Inc., Mayo Medical Laboratories, Novogene Co. Ltd., Qiagen NV, Roche Holding AG, Thermo Fisher Scientific Inc. and Zhejiang Dian Diagnostics Co. Ltd.

Summary

The DNA sequencing industry has achieved significant growth from its beginnings to become a vital sector in life sciences. Illumina, the sequencing leader, has twenty years of sequential revenue growth and the company’s 2018 revenues of approximately $REDACTED billion represented a REDACTED% increase over 2017 revenue. Even with impressive past growth, the industry is still in the early stages of its growth story.

The cumulative number of human genomes sequenced reached REDACTED million as of January 2019 (less than REDACTED% of the global human population); we estimate that population-scale projects alone will increase that figure to more than REDACTED million genomes sequenced by 2023.

Non-human species sequenced as ofJanuary 2019 was less than REDACTED% of all species. These data indicate that there is significant future upside for sequencing across research, metagenomics, agriculture, synthetic biology and clinical applications, among others.

Sequencing plays a central role in several life science megatrends, including precision medicine, synthetic biology, population and consumer genomics; liquid biopsy; tissue-agnostic drugs; blockchain technologies, gene editing, and shift toward consumerism. These major trends favor increasing sequencing adoption and growth in the future.

As an example, in clinical diagnostics there is a move toward a more consumer-focused model. This will drive the demand for genomics technologies because consumers will want to better understand the part that genes and genetic variations have in their future health outcomes.

Key developments in the three key sequencing sectors—research, applied, and clinical–add to the sequencing growth story.

Major developments in the research space include growth of large-scale sequencing initiatives and support for sequencing by the major governmental funding agencies.

Major developments in the applied space include proliferation of population-scale sequencing projects around the globe; use of sequencing by biopharma for selection of patients for clinical trials of precision medicines; and growth in synthetic biology and agriculture applications.

Population-scale sequencing projects, as an example, have multiple positive effects on the sequencing market. These projects give insights into genetic variation within and across populations; advance knowledge of how genetic variation contributes to disease diagnosis, risk prediction and treatment; and facilitate development of new sequencing tools and analysis methods. We have identified more than twenty projects covering the sequencing of the genomes of REDACTED million people by 2023.

Major developments in the clinical space include the launch and rapid growth of NIPT, companion diagnostics for drug development and for tissue-agnostic drugs; and a growing installed base of sequencing instruments for genetic testing. Important clinical sequencing applications include reproductive health; oncology; rare and undiagnosed diseases; and transplant medicine.

Table of Contents

Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Overview
Introduction
Sequencing Markets
Sequencing Growth Driving Forces
Sequencing Applications
Sequencing Industry

Chapter 4 Technology Background
Importance of DNA
Genetic Variation and Analysis
History of Sequencing
Sequencing Technologies
Sanger Sequencing
Next Generation Sequencing
Informatics Technologies
Base Calling
Mapping to a Reference Sequence
Variant Analysis
Clinical Sequencing Adoption Challenges

Chapter 5 Sequencing Initiatives
Sequencing Initiatives
American Gut Consortium
BabySeq
Blood Profiling Atlas
Cancer-ID
Cancer Moon Shots Program
China Precision Medicine Initiative
ClinGen
Epifemcare
France Genomic Medicine Plan
Friends of Cancer Research Project
Human Cell Atlas Consortium
Immunomonitor Consortium
Integration of Imaging and Fluid-based Tumor Monitoring in Cancer Therapy Program
Liquid Biopsies and Imaging for Improved Cancer Care
Lung-Map
Matchmaker Exchange
Metagenomics and Metadesign of Subways and Urban Biomes (MetaSub)
Million Veteran Program
Mind
MedSeq
National Microbiome Initiative
Next Generation Single Cell Analysis Program
Precancer Atlas
Precision Medicine Initiative
Prompt
QuIP Project
TopMed
Population Sequencing Programs

Chapter 6 Research and Applied Applications
Introduction
Research and Development Applications
Applied Applications
Direct to Consumer
Biopharma
Agriculture
Forensics
Microbiome
Synthetic Biology

Chapter 7 Clinical Applications
Introduction
Cancer Applications
Mendelian Disorders Applications
Reproductive Health Applications
Microbiology and Infectious Disease Applications
Complex Disorders Applications
Transplant Diagnostics Applications

Chapter 8 Sequencing Industry
Introduction
Sequencing Instruments Industry
Long Read Sequencing Industry
Target Enrichment and Amplification Industry
Gene Editing Industry
Sequencing Informatics Industry
Sequencing Data-Based Blockchain Industry
Liquid Biopsy Assay Industry
Reproductive Health Diagnostics Industry
Non-invasive Prenatal Testing Industry
Fetal Cell NIPT Industry
Agriculture Industry
Consumer Genomics Industry
DNA Data Storage Industry

Chapter 9 Acquisitions and Strategic Alliances
Acquisitions
Strategic Alliances
Key Trends
2017 Alliances
2018 Alliances
2019 Alliances

Chapter 10 Sequencing Markets
Growth Driving Forces
Sequencing Market
Sequencing Instruments and Consumables Market
Sample Prep Kits and Reagents Market
Informatics Market
Sequencing Services Market
Agriculture Market
Biopharma Market
Consumer Genomics Market
Microbiology Market
Population Genomics Market
Synthetic Biology Market
Clinical Diagnostic Sequencing Market
Cardiology Market
Clinical Microbiology and Infectious Disease Market
Mendelian Disorders Market
Metabolic/Immune Disorders Market
Neurology Market
Oncology Market
Reproductive Health Market
Transplant Market
Single Gene Market
Multigene/Hotspot Market
Exome Sequencing Market
Whole Genome Sequencing Market
Screening/Early Detection Market
Diagnosis Market
Therapy Guidance Market
Monitoring Market
Cancer Clinical Diagnostics Sequencing Market
Lung Cancer Market
Breast Cancer Market
Colorectal Cancer Market
Pan-Cancer Market
Other Cancers
Oncology Screening/Early Detection Market
Oncology Diagnosis Market
Oncology Therapy Guidance Market
Oncology Monitoring Market
Role of Novel Biomarkers for Oncology Therapy Guidance and Monitoring
Reproductive Health Markets
IVF Market
Newborn Screening Market
Carrier Screening Market
NIPT Market
Transplant Market
Geographical Market

Chapter 11 Patent Review/ New Developments
Circulating Tumor Cell Patents
Exosome Patents
Cell-free DNA Patents
Sequencing-Related Patent Disputes
Chapter 12 Company Profiles
3BILLION INC.
10X GENOMICS, INC.
23ANDME INC.
ADAPTIVE BIOTECHNOLOGIES INC.
ADMERA HEALTH
AGILENT TECHNOLOGIES INC.
ALCEDIAG
ALMAC GROUP LTD.
AMARANTUS BIOSCIENCE HOLDINGS INC.
AMBRY GENETICS
APERIOMICS INC.
ARCHER DX
ARUP LABORATORIES
ASTRIDBIO TECHNOLOGIES KFT.
ASURAGEN INC.
ATHENA DIAGNOSTICS INC.
ATRECA INC.
BASE4 INNOVATION LTD.
BAYLOR GENETICS
BECTON, DICKINSON AND CO.
BELLWETHER BIO INC.
BERRY GENOMICS CO. LTD.
BGI SHENZHEN
BIOARRAY S.L.
BIOCEPT INC.
BIODESIX INC.
BIOMARX INC.
BIO-RAD LABORATORIES INC.
BIO-TECHNE LTD.
BLUEPRINT GENETICS
BLUESTAR GENOMICS INC.
BOREAL GENOMICS
CAMBRIDGE EPIGENETIX LTD.
CANCER GENETICS
CAREDX INC.
CARIS LIFE SCIENCES
CEGAT GMBH
CELLMAX LIFE
CELSEE DIAGNOSTICS
CENTOGENE AG
CERGENTIS BV
CHRONIX BIOMEDICAL
CIRCULOGENE THERANOSTICS
CIRCULOMICS INC.
COFACTOR GENOMICS INC.
COLOR GENOMICS
COOPER SURGICAL INC.
CORIELL LIFE SCIENCES INC.
COSMOSID
CS GENETICS LTD.
CYGNUS BIOSCIENCES CO. LTD.
CYNVENIO BIOSYSTEMS INC.
DANAHER CORP.
DATAR CANCER GENETICS LTD.
DARUI BIOTECHNOLOGY CO. LTD.
DEPIXUS
DEVYSER AB
DIACARTA INC.
DIAGNOMICS
DIPLOID
DIRECTED GENOMICS LLC
DIRECT GENOMICS CO. LTD.
DNA ELECTRONICS LTD.
DNANEXUS INC.
DOVETAIL GENOMICS LLC
ELECTRONIC BIOSCIENCES
ENVISION GENOMICS
EPIC SCIENCES INC.
ESPERITE NV
EUROFINS SCIENTIFIC
EXACT SCIENCES CORP.
EXPEDEON AG
EZLIFE BIO INC.
FABRIC GENOMICS
FLUXION BIOSCIENCES INC.
FREENOME INC.
FRY LABORATORIES LLC
FULL GENOMES CORPORATION
FUSION GENOMICS CORP.
GENAPSYS INC.
GENCOVE, INC.
GENDX BV
GENE BY GENE LTD.
GENEDX INC.
GENETICS RESEARCH LLC
GENOMATIX SOFTWARE GMBH
GENOME.ONE PTY LTD
GENOMIC EXPRESSION
GENOMIC HEALTH INC.
GENOME PROFILING LLC
GENOMNIA SRL
GENOMONCOLOGY
GENOSPACE
GENOOX
GENXOSOME TECHNOLOGIES INC.
GIGAGEN INC.
GOLDEN HELIX
GRAIL INC.
GRANDOMICS BIOSCIENCES CO. LTD.
GUARDANT HEALTH INC.
GUARDIOME
HELITEC
HELIX OPCO LLC
HISTOGENETICS LLC
HTG MOLECULAR DIAGNOSTICS INC.
HUMAN LONGEVITY INC.
ILLUMINA INC.
INEX INNOVATIONS EXCHANGE PTE. LTD.
INIVATA LTD.
INTERPACE DIAGNOSTICS LLC.
INVITAE
INVIVOSCRIBE INC.
IREPERTOIRE INC.
KAILOS GENETICS
KARIUS INC.
KELLBENX INC.
KEW INC.
KINGMED DIAGNOSTICS CENTER CO. LTD.
LABORATORY CORP. OF AMERICA INC.
LABORATORY FOR MOLECULAR MEDICINE
LEUCINE RICH BIO PVT. LTD.
LEXENT BIO INC.
LOOP GENOMICS
MACROGEN INC.
MAPMYGENOME
MAYO MEDICAL LABORATORIES
MDXHEALTH
MEDGENOME LABS PVT. LTD.
MENARINI SILICON BIOSYSTEMS SPA
MERCK KGAA
MOGENE LLC
MOLECULAR HEALTH GMBH
MOLECULARMD CORP.
MOLECULAR LOOP BIOSOLUTIONS LLC
MYRIAD GENETICS INC.
NANOSTRING TECHNOLOGIES INC.
NATERA INC.
NAVERIS INC.
NEOGENOMICS LABORATORIES
NEW ENGLAND BIOLABS
NEWGENE LTD.
NEW ONCOLOGY GMBH
NGENEBIO CO. LTD.
NIPD GENETICS
N-OF-ONE INC.
NOVOGENE CO. LTD.
NUGEN TECHNOLOGIES INC.
NUMEDII
NUPROBE INC.
NX PRENATAL INC.
OMNISEQ CORP.
ONCOCYTE CORP.
ONCODNA S.A.
ONEOME LLC
OTHRAM INC.
OXFORD NANOPORE TECHNOLOGIES LTD.
PACIFIC BIOSCIENCES OF CALIFORNIA INC.
PAIRNOMIX INC.
PANGAEA ONCOLOGY
PARADIGM DIAGNOSTICS INC.
PARSEQ LAB CO. LTD.
PATHWAY GENOMICS CORP.
PERKINELMER INC.
PERSONAL GENOME DIAGNOSTICS INC.
PERSONALIS INC.
PIERIANDX
POPULATION GENETICS TECHNOLOGIES LTD.
PORTABLE GENOMICS LLC
POSITIVE BIOSCIENCE
PRECIPIO INC.
PREDICINE INC.
PRENETICS
PREVENTIONGENETICS INC.
QIAGEN NV
QUANTAPORE INC.
QUANTUM BIOSYSTEMS INC.
QUANTUMDX
QUEST DIAGNOSTICS INC.
RARECYTE INC.
REAL TIME GENOMICS INC.
RESOLUTION BIOSCIENCE INC.
ROCHE HOLDING AG
SCREENCELL
SEEKIN
SEQUENCING.COM
SEVEN BRIDGES GENOMICS INC.
SINGLERA GENOMICS INC.
SISTEMAS GENÓMICOS SL
SOFTGENETICS LLC
SOPHIA GENETICS
SPERA MEDICAL
STRAND LIFE SCIENCES PVT. LTD.
STRATOS GENOMICS INC.
SUPRATECH MICROPATH LABORATORY & RESEARCH INSTITUTE PVT. LTD.
SYAPSE
TAKARA BIO INC.
TEMPUS
THERMO FISHER SCIENTIFIC INC.
TRACE GENOMICS INC.
TROVAGENE INC.
TWINSTRAND BIOSCIENCES
TWO PORE GUYS INC.
UBIQUITY GENOMICS INC.
VELA DIAGNOSTICS
VERITAS GENETICS
VORTEX BIOSCIENCES
XING TECHNOLOGIES LLC
YIKON GENOMICS CO. LTD.
YOURGENE HEALTH PLC
ZHEJIANG DIAN DIAGNOSTICS CO. LTD.

Choose License Type

Research Assistance

For Enquiries, Call :

+44-203-322-1521

Email : sales@trendsmarketresearch.com

Send Your Request